Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Woman Pays £200/Month for Life After Quitting Mounjaro - Featured image
GLP-1 Medications

Woman Pays £200/Month for Life After Quitting Mounjaro

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·January 15, 2026·2 min read

On this page

  • Kelly's Initial Success on Mounjaro
  • Challenges After Weaning Off Mounjaro
  • Internal Battle and Decision to Return
  • New Strategy and Current Dosage
  • Lifelong Commitment to Mounjaro
  • Side Effects: Altered Taste and Appetite

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

A woman who shed over four stone on Mounjaro regained weight rapidly after quitting due to overwhelming food noise. She returned to the drug at 5mg, committing to £200 monthly for life to sustain her size 12 figure. Her story highlights GLP-1 challenges in long-term weight management.

Share

On this page

  • Kelly's Initial Success on Mounjaro
  • Challenges After Weaning Off Mounjaro
  • Internal Battle and Decision to Return
  • New Strategy and Current Dosage
  • Lifelong Commitment to Mounjaro
  • Side Effects: Altered Taste and Appetite

Kelly Parish, a 32-year-old talent executive from Sunderland, transformed her health with Mounjaro (tirzepatide), a GLP-1/GIP medication. Starting in October 2024 at over 15.5 stone and size 18, she dropped to 11st 7lbs and size 12 by July 2025. Previously at risk for type 2 diabetes, she credits the drug for her success after years of struggling.

Kelly's Initial Success on Mounjaro

Kelly lost over four stone on Mounjaro, reaching a comfortable weight. The medication curbed her overeating habits, where she once consumed dinners followed by takeaways without feeling full. Her pounds dropped steadily, improving her health outlook.

Challenges After Weaning Off Mounjaro

Thrilled with results, Kelly weaned off Mounjaro, hoping to maintain her figure independently. Within 20 days, the drug left her system, unleashing "insane" food noise. Old habits returned, leading to a 9lb gain in weeks despite gym activity and calorie counting.

  • Cravings for desserts and sweets emerged, unlike her pre-quit self.
  • Late-night snacking derailed progress.
  • She felt like a "child without a parent," missing the drug's guidance.

Internal Battle and Decision to Return

Kelly battled voices urging her back on Mounjaro while fearing judgment as a failure. Prices had risen, but reality hit: she needed it. In October 2025, she restarted with a smarter approach—using it as a guide alongside calorie tracking and exercise.

New Strategy and Current Dosage

Beginning at the lowest dose, Kelly allowed her body to adjust before increasing to 5mg, where she remains. This balances cardio, strength training, and high-protein intake, avoiding past over-reliance. Apps like Shotlee can help track GLP-1 doses for consistency.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Since restarting:

  • Sweet cravings vanished.
  • She lost a stone, erasing regain.
  • Daily calories stay controlled without overeating.

Lifelong Commitment to Mounjaro

"I'm probably going to be on Mounjaro for life," Kelly says. At £200 monthly via installments, it's cheaper than takeaways and obesity risks. She prioritizes health, paying independently to avoid impacting others.

Side Effects: Altered Taste and Appetite

Mounjaro changed Kelly's taste buds, making food less enjoyable. She eats for need, not pleasure—ham sandwiches taste bland, pizzas lose appeal. Hunger hits around 1pm, but fullness comes quickly after a bite, a stark shift from her prior endless eating.

These effects persist, but benefits outweigh them for sustained weight management.

Source Information

Originally published by Kent Live.Read the original article →

Read next

Keep exploring

More on Mounjaro

Articles covering Mounjaro dosing, side effects, and clinical updates.

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks
Health & Wellness

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks

The Food and Drug Administration (FDA) has issued a new warning regarding potential serious kidney complications associated with Alli, the sole over-the-counter weight loss medication available in the United States. The drug's label has been updated to reflect these risks, urging caution for consumers.

8 min read
Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure
Health & Wellness

Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure

GLP-1 receptor agonists, known for their role in diabetes and weight management, are increasingly recognized for their broader health benefits, including effects on blood pressure. This article delves into how these medications work, their impact on cardiovascular health, and whether they are safe for individuals with hypertension.

8 min read
Wegovy Pill Arrives in the UK: A New Era for Weight Management?
Health & Wellness

Wegovy Pill Arrives in the UK: A New Era for Weight Management?

The UK has officially approved a pill version of the popular Wegovy weight-loss drug, marking a significant advancement in accessible obesity treatment. This development offers a convenient alternative to weekly injections for many.

6 min read

Same topic: Mounjaro

All Mounjaro articles →
Mounjaro (Tirzepatide) PBS Listing Fails: Impact on Australian Patients
Pharmaceutical Policy & Access

Mounjaro (Tirzepatide) PBS Listing Fails: Impact on Australian Patients

Eli Lilly Australia has announced that Mounjaro (tirzepatide) will not be listed on the Pharmaceutical Benefits Scheme (PBS) for Type 2 Diabetes, citing unsustainable funding conditions. This decision highlights ongoing challenges in accessing modern GLP-1 and GIP therapies.

6 min read
Lost 9 Stone on Mounjaro: Loose Skin Sparks ElastiK Skin Business
GLP-1 Medications

Lost 9 Stone on Mounjaro: Loose Skin Sparks ElastiK Skin Business

Marc McKee dropped nine stone with Mounjaro, transforming his health but leaving him with loose skin that inspired a new business. ElastiK Skin targets GLP-1 weight loss side effects using peptides, hyaluronic acid, and LED therapy. Early users report better hydration and elasticity with consistent use.

5 min read
Mounjaro Face Effect: Causes and Prevention Tips
GLP-1 Medications

Mounjaro Face Effect: Causes and Prevention Tips

The hype around Mounjaro's weight loss results is real, but so is 'Mounjaro face'—sharper yet tired-looking facial changes from rapid fat loss. Dermatologists and surgeons report more patients with hollowed cheeks and sagging skin seeking help. Experts reveal why it occurs and essential prevention strategies focusing on nutrition and skincare.

6 min read

More in GLP-1 Medications

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39
Health & Wellness

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39

The journey to weight loss can be challenging, and for many, advanced medications like GLP-1 injectables offer a crucial pathway. However, their high cost often presents a significant barrier. Hers is changing this landscape by making popular GLP-1 and other weight loss treatments more accessible and affordable than ever before.

7 min read
Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym
Medical Insights

Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym

For individuals struggling with difficult-to-control type 2 diabetes and weight management, even powerful GLP-1 medications might not be enough. New research highlights the significant role of hypercortisolism and the promising potential of Korlym in optimizing treatment outcomes.

6 min read
Beyond the Needle: New Oral Semaglutide Tech Could Change Weight Loss Forever
Medical Innovation

Beyond the Needle: New Oral Semaglutide Tech Could Change Weight Loss Forever

Duke University researchers have developed a novel oral delivery system for GLP-1 medications that protects peptides from stomach acid, potentially eliminating the need for injections.

8 min read
Share this article
  1. Home
  2. Blog
  3. Woman Pays £200/Month for Life After Quitting Mounjaro
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community